•
Dec 31, 2018

Ironwood Pharmaceuticals Q4 2018 Earnings Report

Total Revenue
$131M
Previous year: $94.2M
+38.7%
EPS
-$0.02
Previous year: -$0.14
-85.7%
U.S. LINZESS Net Sales
$129M
Gross Profit
$109M
Cash and Equivalents
$173M
Free Cash Flow
$5.97M
Total Assets
$332M

Ironwood Pharmaceuticals

Ironwood Pharmaceuticals